CompletedNCT01688895
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Studying Autosomal erythropoietic protoporphyria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Principal Investigator
- Manisha Balwani, MDIcahn School of Medicine at Mount Sinai
- Enrollment
- 150 enrolled
- Eligibility
- All sexes
- Timeline
- 2012 – 2019
Study locations (6)
- University of Alabama, Birmingham, Birmingham, Alabama, United States
- University of California, San Francisco, San Francisco, California, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- University of Texas Medical Branch, Galveston, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
Collaborators
Rare Diseases Clinical Research Network · Office of Rare Diseases (ORD) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01688895 on ClinicalTrials.govOther trials for Autosomal erythropoietic protoporphyria
Additional recruiting or active studies for the same condition.
See all trials for Autosomal erythropoietic protoporphyria →